Interpace Biosciences, Inc. (IDXG)

1.85 +0.05 (+2.78%) USD  |  OTCM  |  Feb 20, 16:00
More

Interpace Biosciences Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for IDXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
FONAR Corp. --
Thermo Fisher Scientific, Inc. Upgrade
XWELL, Inc. Upgrade
Hypha Labs, Inc. --
Veracyte, Inc. Upgrade